Dudediligence.

Neurocrine Biosciences, Inc

NBIXNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$79.9M

25 notices · 510,897 sh

Oct 2025 to Oct 2026

Reported ·

$69.9M

28 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

27 of 28 reported sales carry the 10b5-1 box. Together they are 0.45% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-09-14: MATTHEW C ABERNETHY, Form 1442026-09-14: DAVID WARREN BOYER, Form 1442026-09-09: ERIC BENEVICH, Form 1442026-07-10: INGRID DELAET, Form 1442026-07-09: DARIN LIPPOLDT, Form 1442026-07-07: INGRID DELAET, Form 1442026-06-29: DARIN LIPPOLDT, Form 1442026-06-26: DARIN LIPPOLDT, Form 1442026-06-05: STEPHEN SHERWIN, Form 1442026-06-02: JULIE COOKE, Form 1442026-06-01: JUDE ONYIA, Form 1442026-05-29: INGRID DELAET, Form 1442026-05-27: JUDE ONYIA, Form 1442026-05-26: DAVID WARREN BOYER, Form 1442026-05-19: KEVIN CHARLES GORMAN, Form 1442026-05-15: RICHARD F POPS, Form 1442026-05-12: Norwalk Leslie V, Form 1442026-01-16: KYLE GANO, Form 1442025-12-15: Norwalk Leslie V, Form 1442025-12-08: DARIN LIPPOLDT, Form 1442025-12-03: GARY A LYONS REVOCABLE LIVING U/A DTD 06/08/2012, Form 1442025-11-28: ERIC BENEVICH, Form 1442025-11-25: GEORGE MORROW, Form 1442025-11-05: WILLIAM H. RASTETTER, Form 1442025-11-04: Gano Kyle, Form 1442025-11-04: Gano Kyle, sold2025-11-05: RASTETTER WILLIAM H, sold2025-11-25: MORROW GEORGE J, sold2025-11-28: BENEVICH ERIC, sold2025-12-03: LYONS GARY A, sold2025-12-08: Lippoldt Darin, sold2025-12-15: Norwalk Leslie V, sold2026-01-16: Gano Kyle, sold2026-05-12: Norwalk Leslie V, sold2026-05-15: POPS RICHARD F, sold2026-05-19: GORMAN KEVIN CHARLES, sold2026-05-26: Boyer David W., sold2026-05-27: Onyia Jude, sold2026-05-29: Delaet Ingrid, sold2026-06-01: Onyia Jude, sold2026-06-02: Cooke Julie, sold2026-06-04: Norwalk Leslie V, sold2026-06-05: SHERWIN STEPHEN A, sold
under a ▼ salesize is dollars

Form 144 notices, newest first

2026-09-14MATTHEW C ABERNETHY, Chief Financial Officer$361,024
2,311 shplan 2026-05-22Form 4s on file end Jun 23144 ↗
2026-09-14DAVID WARREN BOYER, Chief Corp. Affairs Officer$736,421
4,714 shplan 2026-02-23Form 4s on file end Jun 23144 ↗
2026-09-09ERIC BENEVICH, Chief Commercial Officer$334,150
2,154 shplan 2026-06-10Form 4s on file end Jun 23144 ↗
2026-07-10INGRID DELAET, Chief Regulatory Officer$788,462
4,367 shplan 2026-02-27Form 4s on file end Jun 23144 ↗
2026-07-09DARIN LIPPOLDT, Chief Legal Officer$1,782,400
10,000 shplan 2025-06-09Form 4s on file end Jun 23144 ↗
2026-07-07INGRID DELAET, Chief Regulatory Officer$2,536,811
14,571 shplan 2026-02-27Form 4s on file end Jun 23144 ↗
2026-06-29DARIN LIPPOLDT, Chief Legal Officer$1,651,496
9,800 shplan 2025-06-09Form 4s on file end Jun 23144 ↗
2026-06-26DARIN LIPPOLDT, Chief Legal Officer$32,836
200 shplan 2025-06-09144 ↗
Form 4, 2026-06-30: sold 10,000 at $170.15 Form 4 ↗
2026-06-05STEPHEN SHERWIN, Director$4,183,750
25,000 shplan 2026-03-06144 ↗
Form 4, 2026-06-09: sold 25,000 at $165.32 Form 4 ↗
2026-06-02JULIE COOKE, Chief Human Resources Officer$5,946,857
36,937 shplan 2026-03-03144 ↗
Form 4, 2026-06-04: sold 36,937 at $156.22 Form 4 ↗
2026-06-01JUDE ONYIA, Chief Scientific Officer$1,741,300
11,000 shplan 2026-02-25144 ↗
Form 4, 2026-06-02: sold 11,000 at $160.25 Form 4 ↗
2026-05-29INGRID DELAET, Chief Regulatory Officer$353,598
2,261 shplan 2026-02-27144 ↗
Form 4, 2026-06-02: sold 2,261 at $156.71 Form 4 ↗
2026-05-27JUDE ONYIA, Chief Scientific Officer$1,713,030
11,000 shplan 2026-02-25144 ↗
Form 4, 2026-05-29: sold 11,000 at $155.53 Form 4 ↗
2026-05-26DAVID WARREN BOYER, Chief Corp. Affairs Officer$609,250
3,888 shplan 2026-02-23144 ↗
Form 4, 2026-05-28: sold 3,888 at $156.64 Form 4 ↗
2026-05-19KEVIN CHARLES GORMAN, Director$38.5M
245,088 shplan 2026-02-17144 ↗
Form 4, 2026-05-21: sold 245,088 at $154.33 Form 4 ↗
2026-05-15RICHARD F POPS, Director$2,385,750
15,000 shplan 2026-02-13144 ↗
Form 4, 2026-05-18: sold 15,000 at $157.65 Form 4 ↗
2026-05-12Norwalk Leslie V, Director$1,028,050
6,310 shplan 2025-09-15144 ↗
Form 4, 2026-05-14: sold 3,810 at $155.01 Form 4 ↗
2026-01-16KYLE GANO, Chief Executive Officer$4,853,940
36,400 shplan 2025-05-20144 ↗
Form 4, 2026-01-20: sold 36,400 at $132.70 Form 4 ↗
2025-12-15Norwalk Leslie V, Director$1,745,000
11,250 shplan 2025-09-15144 ↗
Form 4, 2025-12-17: sold 6,190 at $152.78 Form 4 ↗
2025-12-08DARIN LIPPOLDT, Chief Legal Officer$680,512
4,376 shplan 2025-06-09144 ↗
Form 4, 2025-12-10: sold 4,376 at $159.65 Form 4 ↗
2025-12-03GARY A LYONS REVOCABLE LIVING U/A DTD 06/08/2012, Director$2,287,200
15,000 shplan 2025-09-03144 ↗
Form 4, 2025-12-04: sold 15,000 at $152.61 Form 4 ↗
2025-11-28ERIC BENEVICH, Chief Commercial Officer$904,933
5,970 shplan 2025-08-28144 ↗
Form 4, 2025-12-02: sold 5,970 at $151.74 Form 4 ↗
2025-11-25GEORGE MORROW, Director$2,118,750
15,000 shplan 2025-08-26144 ↗
Form 4, 2025-11-26: sold 15,000 at $143.37 Form 4 ↗
2025-11-05WILLIAM H. RASTETTER, Director$2,577,420
18,000 shplan 2025-08-06144 ↗
Form 4, 2025-11-06: sold 18,000 at $151.82 Form 4 ↗
2025-11-04Gano Kyle, Chief Executive Officer$42,591
300 shplan 2024-11-01144 ↗
Form 4, 2025-11-04: sold 300 at $141.97 Form 4 ↗